The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of hypomethylating agent discontinuation among patients with higher-risk myelodysplastic syndromes.
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Namita Joshi
Employment - Pharmerit
 
Hrishikesh Kale
Employment - Pharmerit
 
Wei-Jhih Wang
Employment - Pharmerit
 
Shelby Corman
No Relationships to Disclose
 
Kala Hill
Employment - Taiho Oncology
Stock and Other Ownership Interests - Celldex; Johnson & Johnson
 
Tehseen Salimi
Employment - Taiho Oncology
 
Robert S. Epstein
Employment - Epstein Health
Leadership - Decipher Biosciences; Fate Therapeutics; Illumina; Proteus Digital Health; Veracyte
Stock and Other Ownership Interests - Decipher Biosciences; Fate Therapeutics; Illumina; Proteus Digital Health; Veracyte
Consulting or Advisory Role - G1 Therapeutics; Halozyme; Intra-Cellular Therapies; Merck; Otsuka; Radius Health; Taiho Oncology
Research Funding - G1 Therapeutics; Taiho Oncology